Naifa L. Busaidy
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, BRCA gene mutations in cancer, Cancer-related Molecular Pathways, Parathyroid Disorders and Treatments, Thyroid and Parathyroid Surgery
Most-Cited Works
- → Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)480 cited
- → Selective RET kinase inhibition for patients with RET-altered cancers(2018)426 cited
- → Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators(2010)420 cited
- → Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019(2020)368 cited
- → NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018(2018)367 cited
- → Parathyroid carcinoma: A 22‐year experience(2004)302 cited
- → Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center(2013)283 cited
- → Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma(2018)239 cited
- → Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway(2012)229 cited
- → Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAF V600E -Mutated Anaplastic Thyroid Carcinoma(2019)226 cited